MiR-1249, as a transcriptional target of p53, inhibited tumor growth, metastasis, and angiogenesis by targeting VEGFa and the high mobility group AT-hook 2 (HMGA2) in colorectal cancer [84]. This evidence concerns the gene HMGA2 and colorectal cancer.